Recent important announcements for Hong Kong stocks are as follows:

Operational data

$TRULY INT'L (00732.HK)$: The cumulative consolidated net turnover for the first 3 months was approximately HK$4.282 billion, an increase of approximately 23.0% over the previous year.

$GREENTOWN CHINA (03900.HK)$: In the first 3 months, cumulative contract sales amounted to 53.2 billion yuan, a year-on-year decrease of 13.21%.

$ZHONGLIANG HLDG (02772.HK)$: In the first 3 months, cumulative contract sales amounted to 5.24 billion yuan, a year-on-year decrease of 54.2%.

$GEMDALE PPT (00535.HK)$: In the first 3 months, cumulative contract sales amounted to 1,807 billion yuan, a year-on-year decrease of 56.96%.

$SUNAC (01918.HK)$: In the first 3 months, cumulative contract sales were 10.0 billion yuan, a year-on-year decrease of 65.84%.

$TIMES CHINA (01233.HK)$: In the first 3 months, cumulative contract sales amounted to 1,526 billion yuan, a year-on-year decrease of 72.01%.

Company news

$COUNTRY GARDEN (02007.HK)$Linklaters has been appointed as the main legal adviser for overseas debt restructuring.

According to the announcement, Country Garden has made positive progress in overseas debt restructuring in cooperation with creditors and key advisors after announcing that it is seeking a comprehensive solution on October 10, 2023. The company has set up a coordination committee representing bank creditors and a project team representing bondholders. Currently, the two parties are discussing information sharing mechanisms and cost arrangements.

In addition, the company has now appointed Linklaters as the main legal adviser for overseas debt restructuring. Linklaters will work with the company and its key advisors to ensure transparent and constructive dialogue between the company and foreign creditors. The company and advisors will explore all possible offshore debt restructuring options with creditors to find an overall solution to the current situation.

$JUNSHI BIO (01877.HK)$: The marketing application for a new indication of treprilimab for first-line treatment of renal cell carcinoma has been approved.

$CHINA OILFIELD (02883.HK)$: The suspension of some drilling platform operations had little impact on the company's drilling sector.

CNOOC Oilfield Services issued an announcement regarding the suspension of operations on some drilling platforms. Some drilling platform operations were suspended due to customer operation plan adjustments. Currently, the company still has several drilling platforms providing services normally in the region.

$EVERG VEHICLE (00708.HK)$The proposed transaction and debt-to-equity swaps will no longer take place.

$SHIMAO GROUP (00813.HK)$: China Construction Bank (Asia) filed a winding-up petition against the company.

Shimao Group announced on the Hong Kong Stock Exchange that China Construction Bank (Asia) Co., Ltd. filed a winding-up petition against the Company with the High Court of the Hong Kong Special Administrative Region on April 5, 2024, involving the Company's financial obligations of approximately HK$1,579.5 billion. The Company believes that the petition does not represent the common interests of the Company's foreign creditors and other interested parties. To protect the interests of its stakeholders, the Company will vigorously oppose the petition and continue to promote overseas debt restructuring to maximize the value of its stakeholders.

Buyback News

$TENCENT (00700.HK)$: Approximately HK$1,003 billion was spent to repurchase 3.25 million shares at a repurchase price of HK$304.4-311.2.

$MEITUAN-W (03690.HK)$: Approximately HK$347 million was spent to repurchase 3.4776 million shares at a repurchase price of HK$97.6-101.1.

$HSBC HOLDINGS (00005.HK)$: Approximately HK$182 million was spent to repurchase 2.982,800 shares at a repurchase price of HK$61.1-61.35.

$CK ASSET (01113.HK)$: A repurchase of 1.932 million shares was spent at HK$61.835 million, with a repurchase price of HK$31.7-32.35.

$XIAOMI-W (01810.HK)$: Spend HK$46.5323 million to repurchase 3 million shares at a repurchase price of HK$15.46-15.54.

$AIA (01299.HK)$: Spend HK$295.24,800 to repurchase 550,000 shares at a repurchase price of HK$53.1-54.45.

$CHINASOFT INT'L (00354.HK)$: It spent approximately HK$23.163,500 to repurchase 5 million shares at a repurchase price of HK$4.49-4.71.

$WUXI BIO (02269.HK)$: 1.485,000 shares were repurchased at HK$19892,500, at a repurchase price of HK$13.32-13.50.

$KUAISHOU-W (01024.HK)$: Spend HK$12.3039 million to repurchase 255,500 shares at a repurchase price of HK$48.9-49.15.

editor/tolk